Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer

14 Nov 2022

Abstract excerpt

Background: Bladder cancer (BLCA) is one of the deadliest diseases, with over 550,000 new cases and 170,000 deaths globally every year. Cuproptosis is a copper-triggered programmed cell death and is associated with the prognosis and immune response of various cancers. Long non-coding RNA (lncRNA) could serve as a prognostic biomarker and is involved in the progression of BLCA. Methods: The gene expression profile...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36451815
DOI: 10.3389/fimmu.2022.1027449

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancerPMID 36451815Read ↗

Prognosis and immune landscape of bladder cancer can be predicted using a novel miRNA signature associated with cuproptosisSemantic proximity Read ↗

Comprehensive analysis of cuproptosis-related long noncoding RNA immune infiltration and prediction of prognosis in patients with bladder cancerSemantic proximity Read ↗

Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancerSemantic proximity Read ↗

A Novel Cuproptosis-Related Two-Gene Signature for Prognostic Prediction in Bladder CancerSemantic proximity Read ↗

Comprehensive analysis of cuproptosis-related genes on bladder cancer prognosis, tumor microenvironment invasion, and drug sensitivitySemantic proximity Read ↗

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma.Semantic proximity Read ↗

A Novel Prognostic Model Based on Cuproptosis-Related Genes and Multi-Omics Analysis Predicts the Prognosis of Patients with Bladder Urothelial CarcinomaSemantic proximity Read ↗

Identification of cuproptosis-related subtypes, the establishment of a prognostic model, and exploration of drug candidates in urothelial carcinomaSemantic proximity Read ↗

Construction of a Risk Model and Prediction of prognosis and immunotherapy Based on Cuproptosis-Related LncRNAs in the Urinary System Pan-CancerSemantic proximity Read ↗

Cuproptosis-related lncRNAs modulate the prognosis of MIBC by regulating the expression pattern of immunosuppressive molecules within the tumor microenvironmentSemantic proximity Read ↗

Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinomaSemantic proximity Read ↗

Construction of a Cuproptosis-Related Signature for Predicting Prognosis and Immune Response in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.